Transforming growth factor‐β‐stimulated clone‐22 is a negative‐feedback regulator of Ras / Raf signaling: Implications for tumorigenesisMasaki Nakamura, Toshio Kitamura, Jiro Kitaura et al.|Cancer Science|2011Cited by 39
Mitotic perturbation is a key mechanism of action of decitabine in myeloid tumor treatmentTomohiro Yabushita, Susumu Goyama, Tomofusa Fukuyama et al.|Cell Reports|2023Cited by 28
The molecular basis of myeloid malignanciesToshio Kitamura, Jiro Kitaura, Daichi Inoue et al.|Proceedings of the Japan Academy Series B|2014Cited by 23
Mitotic Perturbation Is a Key Mechanism of Action of Decitabine in Myeloid Tumor TreatmentTomohiro Yabushita, Susumu Goyama, Takumi Chinen et al.|Blood|2022Cited by 3
The molecular basis of myeloid malignanciesToshio Kitamura, Jiro Kitaura, Daichi Inoue et al.|Proceedings of the Japan Academy|2014Cited by 0